Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letermovir Transplacental Transfer in Second Trimester Pregnancy (CYMEVAL3-STEP1)
NCT04732260Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2021
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of letermovir in cytomegalovirus infection (CMV), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Concentrations reached in fetal blood relative to EC50 of letermovir. Started Jun 2021; status: completed.
02
Drugs
letermovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT04732260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04732260.